Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders??? Equity (Deficit)

v3.21.2
Condensed Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance as of beginning of period (in shares) at Dec. 31, 2019 27,967,896      
Balance as of beginning of period at Dec. 31, 2019 $ 101,858      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Issuance of Series D redeemable convertible preferred stock, net of issuance costs (in shares) 75,660,962      
Issuance of Series D redeemable convertible preferred stock, net of issuance costs $ 28,278      
Exchange of convertible notes and accrued interest for Series D redeemable convertible preferred stock (in shares) 4,029,222      
Exchange of convertible notes and accrued interest for Series D redeemable convertible preferred stock $ 1,512      
Extinguishment of redeemable convertible preferred stock (in shares) (4,456,248)      
Decrease in redeemable convertible preferred stock resulting from the conversion $ (13,274)      
Balance as of end of period (in shares) at Sep. 30, 2020 103,201,832      
Balance as of end of period at Sep. 30, 2020 $ 118,374      
Balance as of beginning of period (in shares) at Dec. 31, 2019   14,721,524    
Balance as of beginning of period at Dec. 31, 2019 (100,823) $ 1 $ 13,195 $ (114,019)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Extinguishment of redeemable convertible preferred stock (in shares)   1,210,513    
Extinguishment of redeemable convertible preferred stock $ 13,274   223 13,051
Issuance of common stock upon exercise of stock options (in shares) 55,000 71,522    
Issuance of common stock upon exercise of stock options $ 53   53  
Stock-based compensation 1,243   1,243  
Net loss (17,591)     (17,591)
Balance as of end of period (in shares) at Sep. 30, 2020   16,003,559    
Balance as of end of period at Sep. 30, 2020 $ (103,844) $ 1 14,714 (118,559)
Balance as of beginning of period (in shares) at Jun. 30, 2020 103,201,832      
Balance as of beginning of period at Jun. 30, 2020 $ 118,374      
Balance as of end of period (in shares) at Sep. 30, 2020 103,201,832      
Balance as of end of period at Sep. 30, 2020 $ 118,374      
Balance as of beginning of period (in shares) at Jun. 30, 2020   15,972,659    
Balance as of beginning of period at Jun. 30, 2020 (97,217) $ 1 14,234 (111,452)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon exercise of stock options (in shares)   30,900    
Issuance of common stock upon exercise of stock options 14   14  
Stock-based compensation 466   466  
Net loss (7,107)     (7,107)
Balance as of end of period (in shares) at Sep. 30, 2020   16,003,559    
Balance as of end of period at Sep. 30, 2020 $ (103,844) $ 1 14,714 (118,559)
Balance as of beginning of period (in shares) at Dec. 31, 2020 117,734,383      
Balance as of beginning of period at Dec. 31, 2020 $ 123,704      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Conversion of warrants into preferred stock, net settlement (in shares) 126,802      
Conversion of warrants into preferred stock, net settlement $ 899      
Conversion of convertible notes into preferred stock (in shares) 6,820,022      
Conversion of convertible notes into preferred stock $ 55,577      
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares) (124,681,207)      
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization $ (180,180)      
Balance as of end of period (in shares) at Sep. 30, 2021 0      
Balance as of end of period at Sep. 30, 2021 $ 0      
Balance as of beginning of period (in shares) at Dec. 31, 2020   16,003,558    
Balance as of beginning of period at Dec. 31, 2020 (107,821) $ 1 14,954 (122,776)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)   126,310,700    
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization 180,180   180,180  
Conversion of warrants into common stock, net settlement (in shares)   239,992    
Conversion of warrants into common stock, net settlement 3,635   3,635  
Issuance of contingent earnout liability upon the reverse recapitalization (120,763)   (120,763)  
Issuance of warrants upon the reverse recapitalization $ (21,051)   (21,051)  
Issuance of common stock upon exercise of stock options (in shares) 200,000 200,444    
Issuance of common stock upon exercise of stock options $ 313   313  
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)   40,409,132    
Issuance of common stock upon the reverse recapitalization, net of issuance costs 278,271 $ 1 278,270  
Issuance of common stock warrants in connection with financing 316   316  
Stock-based compensation 1,751   1,751  
Net loss (92,663)     (92,663)
Balance as of end of period (in shares) at Sep. 30, 2021   183,163,826    
Balance as of end of period at Sep. 30, 2021 $ 122,168 $ 2 337,605 (215,439)
Balance as of beginning of period (in shares) at Jun. 30, 2021 117,734,383      
Balance as of beginning of period at Jun. 30, 2021 $ 123,704      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Conversion of warrants into preferred stock, net settlement (in shares) 126,802      
Conversion of warrants into preferred stock, net settlement $ 899      
Conversion of convertible notes into preferred stock (in shares) 6,820,022      
Conversion of convertible notes into preferred stock $ 55,577      
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares) (124,681,207)      
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization $ (180,180)      
Balance as of end of period (in shares) at Sep. 30, 2021 0      
Balance as of end of period at Sep. 30, 2021 $ 0      
Balance as of beginning of period (in shares) at Jun. 30, 2021   16,168,582    
Balance as of beginning of period at Jun. 30, 2021 (132,414) $ 1 16,446 (148,861)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)   126,310,700    
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization 180,180   180,180  
Conversion of warrants into common stock, net settlement (in shares)   239,992    
Conversion of warrants into common stock, net settlement 3,635   3,635  
Issuance of contingent earnout liability upon the reverse recapitalization (120,763)   (120,763)  
Issuance of warrants upon the reverse recapitalization $ (21,051)   (21,051)  
Issuance of common stock upon exercise of stock options (in shares) 35,420      
Issuance of common stock upon exercise of stock options $ 30   30  
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)   40,409,132    
Issuance of common stock upon the reverse recapitalization, net of issuance costs 278,271 $ 1 278,270  
Issuance of common stock warrants in connection with financing 182   182  
Stock-based compensation 676   676  
Net loss (66,578)     (66,578)
Balance as of end of period (in shares) at Sep. 30, 2021   183,163,826    
Balance as of end of period at Sep. 30, 2021 $ 122,168 $ 2 $ 337,605 $ (215,439)